Literature DB >> 8358772

Sphingosine mobilizes intracellular calcium in human neutrophils.

K Wong1, L Kwan-Yeung.   

Abstract

The effect of sphingosine on the cytosolic free Ca2+ concentrations, [Ca2+]i, of human neutrophils was re-examined using Fura-2 loaded cells. We found that sphingosine induced a dose-dependent elevation of [Ca2+]i. At sphingosine concentrations > or = 10 microM, the rise in [Ca2+]i was biphasic; an initial phase increasing basal [Ca2+]i by 100% was succeeded by a second phase which raised [Ca2+]i to several microM. The enhanced signal was sustained and slowly approached the Fmax of Fura-2 over 10 min. Although cytotoxicity assays indicate that Fura-2 leakage contributed to the rise in fluorescence, EGTA, surprisingly, had no effect on the time course of this response. The explanation was that EGTA blocked Fura-2 leakage from and trypan blue uptake by neutrophils. Thus, in the presence of EGTA, biphasic increases in the fluorescent signal can be attributed mainly to release of intracellular Ca2+. Mn2+ quenching studies confirmed that sphingosine mobilized Ca2+ in two distinct phases and promoted the influx of Mn2+. Mn2+ entry, however, was not matched by substantial Ca2+ influx. Sphingosine elevation of [Ca2+]i was insensitive to pertussis toxin treatment of neutrophils and was not correlated with (1,4,5)IP3 formation. Studies with semi-permeabilized cells show that sphingosine, up to 80 microM, neither mobilized Ca2+ significantly nor inhibited active Ca2+ sequestration. Sphingosylphosphorylcholine induced a small but dose-dependent release of Ca2+. We hypothesize that a metabolite of sphingosine may release Ca2+ directly in intact neutrophils.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358772     DOI: 10.1016/0143-4160(93)90008-t

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  8 in total

1.  Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis.

Authors:  Violeta Romero; Justyna Fert-Bober; Peter A Nigrovic; Erika Darrah; Uzma J Haque; David M Lee; Jennifer van Eyk; Antony Rosen; Felipe Andrade
Journal:  Sci Transl Med       Date:  2013-10-30       Impact factor: 17.956

Review 2.  Sphingolipid metabolites: members of a new class of lipid second messengers.

Authors:  S Spiegel; S Milstien
Journal:  J Membr Biol       Date:  1995-08       Impact factor: 1.843

3.  Sphingosylphosphocholine, a signaling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1.

Authors:  A Berger; D Rosenthal; S Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

4.  Protein phosphatase inhibitors exert specific and nonspecific effects on calcium influx in thapsigargin-treated human neutrophils.

Authors:  K Wong; X B Li
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

5.  Effect of sphingosine derivatives on calcium fluxes in thyroid FRTL-5 cells.

Authors:  K Törnquist; E Ekokoski
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

6.  Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity.

Authors:  Erika Darrah; Jon T Giles; Michelle L Ols; Herbert G Bull; Felipe Andrade; Antony Rosen
Journal:  Sci Transl Med       Date:  2013-05-22       Impact factor: 17.956

7.  Sphingosylphosphocholine modulates the ryanodine receptor/calcium-release channel of cardiac sarcoplasmic reticulum membranes.

Authors:  R Betto; A Teresi; F Turcato; G Salviati; R A Sabbadini; K Krown; C C Glembotski; L A Kindman; C Dettbarn; Y Pereon; K Yasui; P T Palade
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

Review 8.  The Many Facets of Sphingolipids in the Specific Phases of Acute Inflammatory Response.

Authors:  Sabine Grösch; Alice V Alessenko; Elisabetta Albi
Journal:  Mediators Inflamm       Date:  2018-02-06       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.